Significant improvements in glucose were observed with repaglinide ( HBA ( 1c ) : -1.5 % , fasting glucose : -2.8 mmol/L , 2-h glucose : -3.7 mmol/L , AUC ( 120 ) : -18.9 % ) and glibenclamide ( -1.0 % , -2.2 mmol/L , -2.5 mmol/L , -17.5 % ) .
